SOLARA ACTIVE PHARMA Q2 FY27 ; NET PROFIT UP 75% AT ₹28.50 CR (QOQ), VS LOSS OF ₹10.10 CR (YOY)

REVENUE UP 9% AT ₹417.30 CR (QOQ), UP 33% (YOY) EBITDA UP 24% AT ₹77 CR (QOQ), UP 121% (YOY) MARGINS AT 18.4% VS 16.2% (QOQ), 11.1% (YOY)

SOLARA ACTIVE PHA SCI LTD